NUROSENE ANNOUNCES ADVISORY ROLE WITH RARE - X
A company that is focused on being a leader in the development of Artificial Intelligence (AI) solutions targeted at the pharmaceutical industry has announced an advisory relationship with the Global Genes collaborative platform for rare disease patients to share their data to accelerate treatments.
Source: prnewswire.comPublished on 2023-01-18
Related news
- A Dumpling vs Wall St : Why we need synthetics .
- Qatar poised to reap rewards of digital transformation
- A Dumpling vs Wall St : Why we need synthetics .
- The World Is Melting Down and the Cause is Corruption - The G20 Needs to Take Action
- A Dumpling vs Wall St : Why we need synthetics .
- Open Data Economy coming to New Zealand – The Gisborne Herald
- Trace Alliance announces a Working Group on Supply Chain Data Interoperability & Semantic Web , chaired by John G . Keogh
- Red Hat Joins OS - Climate , Lends Open Source Leadership to Financial Services Industry Effort to Address Climate Change
- NUROSENE ANNOUNCES ADVISORY ROLE WITH RARE - X
- The fintech - enabled future for MSMEs | The Manila Times
- A US Propaganda Operation Hit Russia and China With Memes
- Government - owned mega network for South Africa Amazon and Microsoft will not be blocked
- Lockdown is awful – tougher measures are the only way to save lives , says STEPHEN POLLARD
- Celebrating the trailblazers behind waste data this Plastic - Free July
- Former NGA Head to Join Satellite - Imagery Firm